Clinical drug research for the treatment of CNS and neurological disorders

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders.

The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology

The ninth volume of this series "Frontiers in Clinical Drug Research - CNS and Neurological Disorders" showcases another set of state-of-the-art and innovative research ventures produced by the eminent as well as budding scientists in the field of neurodegeneration. They have reviewed, evaluated, and commented to provide a creative futuristic outlook to some of the most exciting latest research findings happening in the field of CNS and Neurological Disorders. This could lead to a better insight into various brain ailments with ground-breaking therapeutic advances and serve as an impetus for future drug development.

Source:
Journal reference:

ur-Rahman, A & Amtul, Z., (2021) Frontiers in Clinical Drug Research - CNS and Neurological Disorders. Bentham Science. doi.org/10.2174/97816810890411210901.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
An unprecedented list of health-threatening fungi released by the WHO